جست‌وجوی استاد و پژوهشگر

Robert W. Amlerمشاهده پروفایل

استاد

• Academic Administration
• Disease Control and Prevention
• Health Policy and Management
• +۵ مورد دیگر

Robert W. Amler, M.D., M.M.S., M.B.A., FAAP, FACPM, is Dean of the School of Health Sciences and Practice and Professor of Public Health and Pediatrics at New York Medical College. He previously served as Chief Medical Officer at the CDC's Agency for Toxic Substances and Disease Registry, where he coordinated anthrax response teams, launched children's health protection programs, and standardized environmental biomarkers. Education: A.B., Dartmouth College M.B.A., New York University M.M.S. and M.D., Robert Wood Johnson Medical School Residencies: NYC Health + Hospitals/Bellevue, CDC Epidemic Intelligence Service His research focuses on children's environmental health , toxicology , and public health policy . He has pioneered work in environmental biomarkers , emergency medicine , and vaccine advocacy . His publications over the past two decades reveal trends in pediatric environmental health , cancer research policy , and epidemiology of childhood disorders . Key topics include uranium exposure , ADHD treatment , and in utero chemical effects . Scientific Awards: William Cullen Bryant Award Outstanding Achievement Award in Epidemiologic Information Application Meritorious Service Medal City & State Reports’ Responsible 100 Award He has advised numerous public health initiatives and held leadership roles including Regional Council Chair for the State Commission on Health Care Facilities in the 21st Century. His work spans pediatric environmental health networks , disaster medicine , and health policy reform .

Priscilla A. Furthمشاهده پروفایل

استاد

• Bioinformatics
• Breast Cancer
• Estrogen Signaling
• +۴ مورد دیگر

Priscilla A. Furth is a Professor at Georgetown University's Department of Oncology and Medicine, with a distinguished career in disease pathophysiology and cancer research. She serves as an Anna Boyksen Fellow at the Technical University of Munich Institute for Advanced Study (TUM-IAS) since 2023, focusing on experimental bioinformatics and gender diversity in science. M.D. from Yale University (1979) Associate Dean for Faculty Development at Georgetown (2013–2021) Her research integrates bioinformatics and gene-regulatory mechanisms to analyze estrogen signaling pathways in breast cancer risk across diverse gender expressions. She pioneered investigations into circular RNA (circRNA) roles as biomarkers and explores their modification through anti-hormonal therapies. Current article trends show interdisciplinary work bridging quantum computing with network medicine , while maintaining focus on hormonal cancer mechanisms and vaccine immunology . Her 2024 publications emphasize multi-omics data integration and gender-inclusive oncology . Scientific recognition includes: 2023 Anna Boyksen Fellowship 2021 Women in Pathology Spotlight 2020 Excellence in Mentorship Award 2010 Georgetown Women in Medicine Award As Associate Dean, she developed faculty growth programs and continues mentoring through her TUM-IAS fellowship collaborations.

• Malaria
• Vaccinology
• Human Genetics
• +۳ مورد دیگر

Adrian Hill is the Lakshmi Mittal Professor of Vaccinology and Director of the Jenner Institute at the University of Oxford. He leads research on vaccines for malaria and other major diseases, with a focus on genetic susceptibility to infection and vaccine delivery technologies. Key Achievements: Founded the Jenner Institute in 2005, which now operates clinical-stage vaccine programs against fifteen diseases. Notable Work: Developed the R21 malaria vaccine with matrix-M adjuvant, showing high efficacy in clinical trials (Lancet, 2021). Global Impact: Spearheaded Oxford's rapid response to the COVID-19 pandemic, resulting in the AstraZeneca vaccine. Research Focus: Malaria vaccine development, human genetics in infectious disease susceptibility, and innovative immunization strategies. His work bridges clinical trials, tropical medicine, and translational research. Scientific Leadership: Recognized through fellowships at the Royal Society, Royal College of Physicians, and Academy of Medical Sciences. He has published over 600 papers with 60,000 citations and co-founded multiple spin-off companies.

Kevin A. Henryمشاهده پروفایل

استاد

• Health Geography
• Geographic Information Systems (GIS)
• Epidemiology
• +۱۲ مورد دیگر

Kevin A. Henry is a Professor and Department Chair in the Department of Geography, Environment, and Urban Studies at Temple University's College of Liberal Arts. He is also an affiliated faculty member with the Global Studies program and the Center for Sustainable Communities. Additionally, he is a member of the Cancer Prevention and Control program at Fox Chase Cancer Center. His educational background includes a Ph.D. in Geography from McGill University (2005) and a postdoctoral fellowship in biostatistics and epidemiology at the same institution. Dr. Henry's research is centered on health geography, with a focus on geospatial analysis methods to study cancer prevention, patient outcomes, and health disparities. His expertise includes spatial statistics, disease mapping, GIS, epidemiology, and life-course perspectives on health. He investigates geographic access to healthcare, particularly cancer screening and treatment, and integrates residential histories into cancer research. His work employs advanced geospatial methods to understand how place influences health outcomes. The recent publications reflect a strong trend in spatial epidemiology, cancer disparities, and geospatial modeling. Key themes include HPV vaccination disparities across rural-urban gradients, socioeconomic and geographic determinants of cancer incidence and stage at diagnosis, and the application of GIS to public health and environmental health. The articles demonstrate interdisciplinary collaboration and a consistent focus on using spatial analytics for health policy and cancer control. Dr. Henry has received research funding from major national agencies including the National Science Foundation (NSF), National Institutes of Health (NIH), Department of Defense (DOD), and American Cancer Society (ACS). He serves on advisory committees and collaborates with the National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC), and North American Association of Central Cancer Registries (NAACCR). He mentors students through the Medical Geography and Population Health Spatial Analytics Laboratory (MAPS Lab), where he supervises graduate and undergraduate research in medical geography. He has taught courses such as Fundamentals of GIS, Health and Medical Geography, GIS for Public Health, Spatial Epidemiology, and Environmental GIS. He is actively recruiting PhD students (starting Fall 2026) and postdoctoral researchers for NIH- and DOD-funded projects. The MAPS Lab conducts applied research using spatial analysis and statistical methods to examine geographic accessibility and place-based health disparities. The lab emphasizes the role of geographic factors in health outcomes, particularly in cancer prevention and care, and engages in interdisciplinary collaborations and national data initiatives.

Peter Lloyd-Sherlockمشاهده پروفایل

استاد

• Social policy in developing countries
• Ageing and population ageing
• Health and wellbeing of older people
• +۱۲ مورد دیگر

Peter Lloyd-Sherlock is Professor and Research Associate at the School of Global Development, University of East Anglia. He is a member of the research groups on Health and Disease and Life Course, Migration and Wellbeing. His work focuses on the intersection of social policy, health, and ageing in developing countries, with extensive fieldwork in Latin America, sub-Saharan Africa, and Southeast Asia. PhD in Social Policy, London School of Economics (1994) MA in Area Studies (Latin America), London School of Economics (1991) BA in Geography, University of Oxford (1988) His research interests include social protection, non-communicable diseases, long-term care, and the economic and social impacts of population ageing. He has led major projects using WHO SAGE and 10/66 Dementia Research Group data, analyzing how pensions, healthcare access, and social policies affect older adults’ wellbeing. He is particularly known for his work on care dependence and health equity in low- and middle-income countries. The most recent articles highlight a consistent focus on health systems, ageing, and equity, particularly in the context of the COVID-19 pandemic. Themes include vaccine ethics, integrated care models, and the socioeconomic burden of chronic illness. His research spans public health, development studies, gerontology, and policy analysis, with strong emphasis on empirical, cross-national comparisons. Scientific Awards and Recognition Primary author of the United Nations Report: Guide to the National Implementation of the Madrid International Plan of Action on Ageing (2008) He has supervised numerous research students and collaborated with international agencies including the World Health Organization, the UN, and UK government departments. His projects have been funded by the Medical Research Council, Economic and Social Research Council, and UK Research & Innovation. He is Joint Director of Research for the School of International Development and contributes to policy debates on ageing and development. His research groups include Ageing and Development, Health Policy and Practice, and the HIV and Development Group, reflecting interdisciplinary engagement with global health and development challenges.

Karen D'Angeloمشاهده پروفایل

استادیار

• Social Work
• Criminology
• Anti-Oppressive Education
• +۳ مورد دیگر

Karen D'Angelo serves as Assistant Professor and Coordinator of the B.S.W. Program within the Department of Social Work at Southern Connecticut State University, holding office in LA 113 with contact dangelok1@southernct.edu and (203) 392-8373. Her research program critically examines intersections of systemic oppression through multiple lenses: Criminal-legal system impacts on undergraduate student populations Implementation of anti-oppressive frameworks in social work pedagogy Health equity barriers within marginalized communities Recent publications demonstrate methodological rigor in exploring criminal-legal system navigation by students and innovative anti-racist approaches to research methods instruction. These works collectively advance social work's commitment to dismantling structural inequities through both scholarly inquiry and classroom practice. Dr. D'Angelo actively secures external funding for community-centered research, notably serving as Co-Principal Investigator on CDC-funded initiatives addressing: Vaccine access disparities in Black and Latinx Connecticut communities (2021-2022) Barriers to healthcare confidence among racially marginalized populations

Tracy Rosebrockمشاهده پروفایل

استادیار

• Microbiology
• Plant Pathology
• Immunology
• +۴ مورد دیگر

Tracy Rosebrock serves as Assistant Professor of Biology at Stonehill College, where she was honored with the 2022 Louise F. Hegarty Award for Excellence in Teaching. Her teaching excellence is characterized by compassionate mentorship, challenging yet supportive pedagogy, and an open-door policy that has made her a trusted advisor. Students consistently praise her ability to simplify complex biological concepts while inspiring academic excellence and fostering a positive learning environment. Professor Rosebrock's research spans two critical areas of pathogen-host interactions: tuberculosis immunology and plant-microbe dynamics. Her tuberculosis work investigates macrophage signaling pathways, antibiotic resistance mechanisms in mycobacteria, and antibody-mediated immune responses. In plant pathology, she examines ubiquitin-mediated immune regulation, bacterial effector proteins that suppress host defenses, and viral disease emergence. This dual focus demonstrates her interdisciplinary approach to understanding fundamental biological defense mechanisms across kingdoms. Her publication record from 2002-2019 reveals consistent contributions to understanding host-pathogen conflicts, with recent work emphasizing immune signaling in tuberculosis control and ubiquitin pathways in plant immunity. These research trajectories highlight her commitment to addressing both human health challenges and agricultural security through molecular investigation. Scientific Recognition: Louise F. Hegarty Award for Excellence in Teaching (2022) - Stonehill College's highest teaching honor, awarded for transformative student impact and pedagogical excellence As an academic advisor, Professor Rosebrock maintains an exceptionally supportive relationship with students, described as "a listening ear, a shoulder to cry on, and a mentor." Her teaching philosophy integrates Aristotle's principle that "educating the mind without educating the heart is no education at all," creating classrooms where students feel empowered to reach their highest potential. While specific research grants aren't detailed in available materials, her sustained publication output indicates active research programs in microbiological and plant pathological systems.

• Cancer Immunotherapy
• Stem Cell Transplantation
• Multiple Myeloma
• +۳ مورد دیگر

Aaron P. Rapoport serves as the Gary Jobson Professor of Medical Oncology and Professor in the Department of Medicine at the University of Maryland School of Medicine. He holds dual leadership roles as Associate Chief of the Hematology/Oncology Division and Director of the Blood and Marrow Transplant Program at the UM Marlene and Stewart Greenebaum Comprehensive Cancer Center. His educational background includes a B.S. from Massachusetts Institute of Technology (1982) and M.D. from Harvard Medical School (1986), followed by postgraduate fellowships at University of Rochester/Strong Memorial Hospital (1989, 1993). Dr. Rapoport's research pioneers adoptive T-cell therapies for hematologic malignancies, with groundbreaking work in: Costimulated autologous T-cell infusions post-transplant MAGE-A3/Poly-ICLC vaccine combinations for myeloma High-affinity TCR gene-modified T cells Immune reconstitution strategies after stem cell transplantation His publication record (2005-2015) reveals an evolutionary trajectory from foundational immune recovery studies to advanced engineered cellular therapies, consistently targeting multiple myeloma through integrated vaccine and T-cell approaches. As Principal Investigator, he has secured major funding including: NHLBI R01-CA166961 (2012-2015) for gene-modified T-cell therapy Multiple Myeloma Research Foundation Senior Award (2013-2015) NHLBI R21 (2009-2010) for hTERT-based immunotherapy He directs the Blood and Marrow Transplant Program's translational research team, which has conducted over 6 clinical trials involving 150+ patients to develop novel cellular immunotherapies for hematopoietic cancers.

Karen Kotloffمشاهده پروفایل

استاد

• Infectious Disease Epidemiology
• Vaccine Development
• Clinical Trials
• +۸ مورد دیگر

Karen Kotloff, MD, is a Professor in the Department of Pediatrics at the University of Maryland School of Medicine. She serves as Head of the Division of Infectious Disease and Tropical Pediatrics and Associate Director of Clinical Studies at the Center for Vaccine Development and Global Health (CVD). Her work spans clinical practice, research leadership, and international public health initiatives. Education: BA in Psychology (Washington University, 1975), MD (Temple University School of Medicine, 1979) Secondary Appointments: Medicine, Epidemiology & Public Health Dr. Kotloff specializes in pediatric infectious diseases and vaccine development. Her research focuses on global child mortality reduction through clinical trials and epidemiological studies, particularly in developing countries. Key projects include the GEMS, VIDA, CHAMPS, and SANTE studies, addressing diarrheal diseases, pneumonia, and maternal-infant mortality prevention. Her scientific contributions have earned international recognition, including the Knight of the National Order of Mali (2005), Temple University Alumni Achievement Award (2019), and Founders' Day Research of the Year (2018). She leads multiple NIH- and Gates Foundation-funded initiatives, including Phase 3 COVID-19 vaccine trials and azithromycin distribution programs. Selected Awards Chevalier de l’Ordre National du Mali (2005) Distinguished Professor (2021) Temple University Alumni Achievement Award (2019) Founders' Day Research of the Year (2018) Baltimore Magazine’s Best Doctors (2013-2014) Alexander I. Shaeffer Teaching Award (1987-1988) Dr. Kotloff participates in international advisory committees for the Bill & Melinda Gates Foundation and the World Health Organization, advancing vaccine implementation strategies in Africa and Asia.

Ujjwal Neogiمشاهده پروفایل

مدرس ارشد

• Virology
• Immunometabolism
• Systems Biology
• +۱۱ مورد دیگر

Ujjwal Neogi is a Senior Lecturer and Docent at Karolinska Institutet, where he leads The Systems Virology Lab within the Department of Laboratory Medicine. His research focuses on understanding viral pathogenesis through the lens of immunometabolism and systems biology. He also holds teaching positions at both Karolinska Institutet and Manipal Institute of Virology in India. Dr. Neogi earned his PhD from the Department of Medicine, Huddinge, Karolinska Institutet in 2013 and was awarded Docent status in 2018. His academic journey reflects a strong foundation in medical virology and immunology. Neogi's research program centers on the metabolic rewiring that occurs during RNA virus infections, particularly focusing on HIV, SARS-CoV-2, Crimean-Congo hemorrhagic fever virus (CCHF), Japanese encephalitis virus (JEV), and Dengue viruses. His lab pioneered systems biology approaches to fingerprint metabolic changes during viral infection and develop novel functional cure strategies by engineering the metabolic state of immune cells. A significant portion of his work examines inflamm-aging in people living with HIV on successful therapy. His publication record shows a strong focus on multi-omics approaches to understand host-pathogen interactions, with particular emphasis on metabolic reprogramming during viral infections. Recent work has expanded to include studies on long-term complications of successful HIV therapy, neurological impacts of viral infections, and the role of gut microbiome in immune development and disease progression. Dr. Neogi actively supervises doctoral students and postdoctoral fellows, and teaches across multiple levels including bachelor's, master's, and doctoral programs. His courses cover molecular and clinical virology, emerging and re-emerging infectious diseases, systems biology in infectious diseases, and diagnostic virology. The Systems Virology Lab operates as part of Karolinska Institutet's Department of Laboratory Medicine and collaborates with multiple research teams including those studying immuno-metabolic reprogramming, innate immune responses, stem cell and organoid models, and the Systems Infection Biology facility which provides advanced bioinformatics analysis services.

• Microbiology
• Immunology
• Bacterial Pathogenesis
• +۷ مورد دیگر

Paul Brett is a Professor in the Department of Microbiology and Immunology at the University of Nevada, Reno School of Medicine. With over 25 years of experience researching Burkholderia pseudomallei , the causative agent of melioidosis, Dr. Brett leads a laboratory focused on understanding molecular mechanisms of bacterial pathogenesis and developing effective vaccines against this significant infectious disease. Dr. Brett received his B.Sc. in Biochemistry from the University of Victoria and his Ph.D. in Bacterial Pathogenesis from the University of Calgary. His academic credentials have supported a distinguished career investigating bacterial virulence mechanisms, particularly focusing on how B. pseudomallei evades host immune defenses through specialized surface structures. Dr. Brett's research program centers on elucidating how lipopolysaccharides and capsular polysaccharides expressed by B. pseudomallei contribute to immune evasion. His laboratory has developed significant expertise in carbohydrate purification/characterization, glycoconjugate synthesis, and comprehensive analysis of humoral/cellular immune responses. The ultimate goal of his research is to identify correlates of antigen-induced immunity against B. pseudomallei to develop safe, affordable, and effective melioidosis vaccines that could address this serious public health threat. Analysis of Dr. Brett's publication history reveals a consistent research trajectory with publications spanning from the early 2000s through 2025. His work demonstrates increasing sophistication in vaccine development approaches, with recent publications focusing on glycoconjugate vaccines, structural analysis of bacterial components, and innovative diagnostic methods for melioidosis. His research bridges molecular microbiology and translational immunology, with direct applications to vaccine design and development. Dr. Brett has participated in significant collaborative efforts, including the Melioidosis Diagnostic Workshop in 2013 and the Steering Group on Melioidosis Vaccine Development. These collaborations highlight his standing as a recognized expert in the field and his commitment to advancing international efforts to combat melioidosis. Though specific details about current students and grants are not provided in the available materials, Dr. Brett's active publication record through 2025 and his laboratory's described capabilities suggest he maintains a vibrant research program with ongoing funding and mentorship of graduate students and postdoctoral researchers. His work has direct relevance to both public health initiatives in melioidosis-endemic regions and biodefense preparedness efforts given B. pseudomallei 's classification as a Tier 1 select agent.

• Malaria
• Global Health
• Pediatric Infectious Diseases
• +۷ مورد دیگر

Miriam K. Laufer, MD is an Adjunct Professor in the Department of Pediatrics at the University of Maryland School of Medicine, with secondary appointments in Medicine, Epidemiology and Public Health, and Faculty of the graduate program in Microbiology and Immunology. She directs the Malaria Research Program at the Center for Vaccine Development and Global Health, serves as Director of the Office of Student Research for the School of Medicine, and is Associate Director of the Institute for Global Health at the University of Maryland. Dr. Laufer received her medical degree from the University of Pennsylvania and completed her pediatric residency at Babies and Children's Hospital of New York (now New York Children's Hospital) of Columbia University. She completed fellowships in pediatric infectious diseases at Johns Hopkins University and in malaria research at the Center for Vaccine Development at the University of Maryland. She earned her MPH from the Bloomberg School of Public Health at Johns Hopkins University. As a pediatric infectious disease specialist, Dr. Laufer has dedicated nearly two decades to malaria research in Malawi. Her primary research focuses on the impact of infections including malaria and HIV during pregnancy on infant immunity and early childhood development, the interaction between HIV and malaria, and identifying reservoirs of malaria transmission. Her laboratory applies molecular epidemiology tools to address critical issues related to malaria pathogenesis, disease burden, and drug resistance. She uses clinical and laboratory research to develop and evaluate interventions to decrease the malaria burden in sub-Saharan Africa. Dr. Laufer's recent publications demonstrate a strong emphasis on malaria prevention strategies, particularly for vulnerable populations. Her work explores school-based interventions, comparative effectiveness of antimalarial drugs during pregnancy, molecular mechanisms of malaria transmission, and HIV-malaria co-infections. Her research has significantly contributed to understanding the role of school-age children as malaria reservoirs and has informed malaria prevention policies across sub-Saharan Africa. Joseph Augustine LePrince Award (American Society of Tropical Medicine and Hygiene) J. Tyson Tildon Award for Pediatric Research Alpha Omega Alpha Teaching Commendation (Host Defenses and Infectious Diseases) Global Health Faculty Award (Center for Global Health Initiatives) American Society of Tropical Medicine and Hygiene LePrince Medal As Principal Investigator for clinical trials, epidemiological studies, and a Fogarty training grant, Dr. Laufer leads collaborative research across the US, Europe, and Africa. She is deeply committed to training the next generation of scientists through the Malaria Research Program, which focuses on building research capacity in both the US and malaria-endemic countries. She also serves as Director of the Office of Student Research, promoting hands-on research training for all medical students. Dr. Laufer directs the Malaria Research Program at the Center for Vaccine Development and Global Health, which develops innovative scientific tools to eliminate malaria. She serves on the World Health Organization's Malaria Vaccine Advisory Committee and Global Malaria Programme Guidelines Development Committee, and is active in the American Society of Tropical Medicine and Hygiene and Pediatric Infectious Diseases Society.

• Public Health Science
• Health Economics
• Injury and Violence Prevention
• +۶ مورد دیگر

Koustuv Dalal is a Professor in Public Health Science at Mid Sweden University's Department of Health Sciences. His work spans health economics, injury prevention, global health, and implementation science, with a focus on violence prevention and policy advocacy. Key Roles: Editor-in-chief of Health Economics Review, Senior Editorial Board Member at BMC Health Services Research, and former WHO Collaborating Centre for Safe Communities (2007-2017). Collaborations: Over 50 universities/institutes across 40+ countries. Research interests include economic evaluations, eHealth interventions, and participatory approaches to policy development. His recent publications analyze IPV determinants, pandemic recovery, ocular morbidity costs, and healthcare worker well-being. Scientific recognition includes the 2017 WHO Distinguished Career Award and Fellowship in the Royal Society for Public Health. He supervises PhD students and leads international workshops on health economics and safety promotion.

Jan C. Fransooمشاهده پروفایل

استاد

• Supply Chain Management
• Logistics
• Operations Management
• +۹ مورد دیگر

Jan C. Fransoo is Professor of Operations and Logistics Management at the Tilburg School of Economics and Management, Tilburg University. He maintains significant affiliations with MIT's Center for Transportation and Logistics as a Research Affiliate and with Technische Universiteit Eindhoven as a Visiting Professor. His research bridges academic rigor and practical application through extensive collaborations with multinational corporations, technology startups, and intergovernmental organizations including the World Bank and Interamerican Development Bank. His educational background includes: PhD in Production Control and Demand Management in Capacitated Flow Process Industries, Technische Universiteit Eindhoven (1989-1993) Master's Degree in Industrial Engineering and Management Science, Technische Universiteit Eindhoven (1984-1989) Professor Fransoo's research focuses on supply chain and operations management , with pioneering work on "nanostores" - his term for the 50 million mom-and-pop stores serving populations in developing regions. He also conducts significant research in urban logistics, omnichannel retail, and human-AI collaboration in supply chain decision-making. His methodology combines model-based and empirical quantitative approaches with practical field research, often developed in close partnership with industry stakeholders across multiple continents. His recent publications reveal a strong trend toward addressing real-world supply chain challenges in developing economies, particularly focusing on nanostore operations, financial constraints affecting small retailers, and the role of technology in enhancing supply chain resilience. His work consistently bridges theoretical innovation with practical applicability, as evidenced by his leadership in the Dutch national COVID-19 vaccination program deployment. Among his notable recognitions: M&SOM Journal Meritorious Service Award (2016) Salzberg Medallion (2022) University Medal from Eindhoven University of Technology (2017) Paper selected for virtual special issue in Transportation Science (2021) Professor Fransoo has supervised over 30 PhD students throughout his career, with current advisees researching nanostore logistics, human-AI decision making, and public health operations. His research is supported by collaborations with major organizations including ASML, ABInbev, Grupo Bimbo, and the World Bank. Notably, in 2021 he led a volunteer team that significantly accelerated the Dutch national vaccination campaign. He actively contributes to national logistics policy through Dinalog (the Dutch Institute for Advanced Logistics) and serves on the Independent Advisory Committee for the National Mobility Vision 2050. His current research continues to explore the complex dynamics of retail supply chains in developing economies and the transformative potential of digital technologies in global logistics operations.

• Infectious Diseases
• Tuberculosis Research
• Immunology
• +۵ مورد دیگر

Professor Jon Friedland serves as Vice-President (Research & Innovation) at City St George's, University of London, a position he assumed in January 2025 following the merger of City University and St George's. Previously, he was Deputy Vice-Chancellor (Research and Enterprise) and Professor of Infectious Diseases at St George's, University of London. His extensive leadership experience includes Director (initially Dean) of the Hammersmith Campus at Imperial College London (2010-18), Head of Infectious Diseases, and Lead Clinician for Clinical Infection (2004-13). Beyond academia, he serves as a non-executive board member of the UK Health Security Agency, chairing the Science & Research Committee and serving on the Audit & Risk Committee. Friedland's research spans two primary domains: the innate inflammatory immune response to tuberculosis (TB), with particular focus on matrix metalloproteinases driving tissue destruction in pulmonary and central nervous system tuberculosis; and migration and infection, examining active/latent TB in migrants, healthcare barriers, and neglected tropical diseases. His work on host-directed therapies for TB, prevention of long-term fibrosis, and the immunopathology of neurocysticercosis has resulted in over 250 publications. His research methodology emphasizes collaborative international work across five continents, with longstanding partnerships at Johns Hopkins University and Universidad Cayetano Heredia Peruan in Lima, Peru. The analysis of Professor Friedland's most recent publications reveals a sustained focus on TB immunopathology, particularly the role of matrix metalloproteinases in tissue destruction. His work increasingly examines the intersection of TB with migration, mental health, and co-infections, reflecting a growing emphasis on social determinants of health. The publications demonstrate methodological diversity spanning basic science, clinical research, systematic reviews, and implementation studies, with significant contributions to clinical guidelines and policy recommendations through organizations like ESCMID and TBnet. Weber-Parkes Prize Medal for research in tuberculosis (2005) Fellow of the Academy of Medical Sciences (2008) Fellow of the Royal College of Physicians of Ireland (2010) Inaugural Fellow of the European Society of Clinical Microbiology and Infectious Diseases (2017) President of the British Infection Society (2007-2009) Professor Friedland has chaired significant committees including the MHRA Expert Working Group on COVID-19 Therapeutics and the Commission for Human Medicines Expert Working Group. His leadership extends to the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), where he currently serves as President-elect and Secretary General after previously serving as Scientific Affairs Officer. His work with international collaborators has secured substantial research funding for studies on TB immunopathology and migrant health, with particular emphasis on translating basic science discoveries into clinical applications through host-directed therapies. His research program operates through an international collaborative network spanning five continents, with particularly strong partnerships in Peru through Universidad Cayetano Heredia and in the United States with Johns Hopkins University. This global network enables studies on TB in diverse epidemiological settings and facilitates research on migrant health across different healthcare systems. The collaborative approach has been instrumental in advancing understanding of TB immunopathology across different populations and settings.